Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NYSE

BMO Capital & Credit Suisse Slash United States Steel Price Target - Read Why

BMO Capital analyst David Gagliano lowered the price target on United States Steel Corp (NYSE:X) to $23 (an upside of 15.5%) from $30 while maintaining the Market Perform rating on the shares. X provided its 'mid-quarter' update yesterday and mentioned that it expects 2Q22 EBITDA of $1.6 billion, vs. BMO/FactSet consensus of $1.5 billion. Related: United…

Benzinga

Where HCA Healthcare Stands With Analysts

Analysts have provided the following ratings for HCA Healthcare (NYSE:HCA) within the last quarter:

Benzinga

Analyst Ratings for Universal Health Services

Within the last quarter, Universal Health Services (NYSE:UHS) has observed the following analyst ratings:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Where Humana Stands With Analysts

Humana (NYSE:HUM) has observed the following analyst ratings within the last quarter:

Benzinga

What 4 Analyst Ratings Have To Say About Century Communities

Within the last quarter, Century Communities (NYSE:CCS) has observed the following analyst ratings:

Benzinga

Why This NextEra Energy Partners Analyst Is Turning Bullish

NextEra Energy Partners LP (NYSE: NEP) has flattened the incentive distribution rights (IDR) fees with its indirect wholly-owned subsidiary NextEra Energy Inc. (NYSE: NEE), according to RBC Capital Markets.

Benzinga

Mizuho Cuts WEC Energy's Price Target By 13%

Mizuho Securities analyst Anthony Crowdell lowered the price target on WEC Energy Group Inc (NYSE:WEC) to $93 (an upside of 3%) from $107 while maintaining the Neutral rating on the shares. Mizuho hosted investor meetings with WEC’s Executive Chairman Gale Klappa and CFO Xia Liu. Crowdell says that the management highlighted the strong 6-7% EPS…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

BMO Sees 'Differentiated Gene Editing Platform' For This Small-Cap Stock

BMO Capital Markets initiated the coverage on Precision BioSciences Inc (NASDAQ:DTIL) with an Outperform rating and a price target of $7. The analyst said the thesis is based on: The company's proprietary gene-editing platform, whose mechanism is differentiated in a CRISPR-dominated space, offers several advantages. A diversified pipeline. Asymmetric risk/reward skewed to the upside.…

Benzinga

Centene Lifts FY22 Guidance On Higher Medicaid Premiums; Increases Share Buyback

Ahead of its investor day, Centene Corp (NYSE:CNC) increased its Premium and Service Revenues FY22 guidance range by $2.0 billion to $134.3 billion - $136.3 billion. The company also increased adjusted EPS guidance by $0.15 to $5.55 - $5.70 vs. the consensus of $5.49. The company's 2022 financial guidance has been updated to…

Benzinga

33 Stocks Moving In Friday's Mid-Day Session

Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.

Benzinga

What 5 Analyst Ratings Have To Say About ChargePoint Hldgs

Within the last quarter, ChargePoint Hldgs (NYSE:CHPT) has observed the following analyst ratings:

Benzinga

Petrobras Brasileiro Whale Trades For June 17

A whale with a lot of money to spend has taken a noticeably bearish stance on Petrobras Brasileiro. Looking at options history for Petrobras Brasileiro (NYSE:PBR) we detected 21 strange trades.

Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today

Truist Financial (NYSE:TFC) has outperformed the market over the past 5 years by 15.81% on an annualized basis producing an average annual return of 24.3%. Currently, Truist Financial has a market capitalization of $61.36 billion.

Benzinga

UBS Maintains Buy Rating for Keysight Technologies: Here's What You Need To Know

UBS has decided to maintain its Buy rating of Keysight Technologies (NYSE:KEYS) and lower its price target from $220.00 to $177.00. Shares of Keysight Technologies are trading up 1.86% over the last 24 hours, at $133.49 per share.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What To Know About JP Morgan's Upgrade of ZIM Integrated Shipping

JP Morgan upgraded its rating of ZIM Integrated Shipping (NYSE:ZIM) to Neutral with a price target of $53.30, changing its price target from $43.60 to $53.30. Shares of ZIM Integrated Shipping are trading up 2.17% over the last 24 hours, at $49.86 per share.

Benzinga

$1000 Invested In UnitedHealth Group 10 Years Ago Would Be Worth This Much Today

UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 10 years by 12.08% on an annualized basis producing an average annual return of 22.77%. Currently, UnitedHealth Group has a market capitalization of $425.55 billion.

Benzinga

Merck Shows Takeover Interest In Seagen: WSJ

Merck & Co Inc (NYSE:MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens, it would be significant, given Seagen's market value of roughly $28 billion. According to the report, some people said other unnamed suitors are also eying Seagen, a…

Benzinga

Where American Eagle Outfitters Stands With Analysts

Analysts have provided the following ratings for American Eagle Outfitters (NYSE:AEO) within the last quarter:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Analyst Ratings for Envista Holdings

Within the last quarter, Envista Holdings (NYSE:NVST) has observed the following analyst ratings:

Benzinga

Analyst Ratings for UnitedHealth Group

Analysts have provided the following ratings for UnitedHealth Group (NYSE:UNH) within the last quarter:

Benzinga

Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Nod For Kids As Young As Six Months

The FDA has granted emergency use authorization (EUA) to Pfizer Inc (NYSE:PFE) and BioNTech SE's (NASDAQ:BNTX) COVID-19 Vaccine as a three 3-µg dose series for children six months through 4 years of age. Based on safety, tolerability, and immunogenicity data, the 3-µg dose was carefully selected as the preferred dose for children under five. The EUA…

Benzinga

Ominous Death Cross Forms On Omnicom Group's Chart

If history is any guide, there may be trouble ahead for shares of Omnicom Group (NYSE:OMC). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Tuesday Is Your Last Chance To Buy Federated Hermes Premier Before The Dividend Payout

Tuesday marks the last chance for investors to receive the next dividend payout from Federated Hermes Premier (NYSE:FMN).

Benzinga

Redwood Trust: Dividend Insights

Tuesday marks the last chance for investors to receive the next dividend payout from Redwood Trust (NYSE:RWT).

Benzinga

Tuesday Is Your Last Chance To Buy Carrier Global Before The Dividend Payout

Tuesday marks the last chance for investors to receive the next dividend payout from Carrier Global (NYSE:CARR).

1 … 200 201 202 203

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.